Ibuprofen Active Pharmaceutical Ingredient (API) Market Analysis Asia,North America,Europe,Rest of World (ROW) - US,Germany,UK,India,China - Size and Forecast 2023-2027
| Published: Oct 2023 | Pages: 151 | SKU: IRTNTR75040 |
Ibuprofen API Market Forecast 2023-2027
The ibuprofen active pharmaceutical ingredient (API) market is estimated to grow by USD 31.68 million at a CAGR of 2.53% between 2022 and 2027. The growth of the market depends on several factors, including the increasing geriatric population, the evolving API manufacturing scenario in developing countries, and the increase in pharmaceutical and biopharmaceutical production.
It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
What will be the size of the Ibuprofen API Market During the Forecast Period?
To learn more about this report, Download Report Sample
Market Dynamics
The increasing geriatric population is notably driving the market, although factors such as stringent regulations may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Driver
The increasing geriatric population is notably driving the market. The risk of contracting chronic illness increases with age, which, in turn, fuels the demand for ibuprofen APIs. According to the Centers for Disease Control and Prevention (CDC), the number of US adults aged 65 years and above is expected to reach approximately 71 million. This will increase the diagnosis of age-related diseases in the susceptible patient population, which will fuel the adoption of different therapeutics.
The growth in the geriatric population increases the burden on the national health system. As a result, healthcare financing has become a critical policy issue. Therefore, national healthcare regulatory bodies promote the use of generic drugs to reduce the impact of economic burden. This, in turn, increases the penetration of generic drug manufacturers in the US and Europe. Such manufacturers outsource raw materials from ibuprofen API manufacturers to provide cost-effective therapeutics. This, in turn, will contribute to the global market during the forecast period.
Significant Market Trend
The paradigm shift in API manufacturing is a key trend influencing the market. Many pharmaceutical companies outsource a large share of their research and manufacturing processes to drug manufacturing organizations. Outsourcing is done due to several factors, such as industry trends, the high cost of acquiring new technologies, and the availability of internal capacity.
Outsourcing the manufacturing of ibuprofen APIs is helpful for small organizations that do not have the internal capacity and financial budget to manufacture ibuprofen APIs in-house. It also saves time invested in manufacturing. Outsourcing of ibuprofen APIs enables innovators and manufacturers to meet development timelines while capitalizing on high efficiency in their supply chain. Therefore, the paradigm shift from captive ibuprofen API manufacturing to contract ibuprofen API manufacturing is anticipated to have a positive impact on market during the forecast period.
Major Market Challenge
Stringent regulations are challenging market. Regulatory authorities need to evaluate drug-related data carefully before approval. They examine aspects such as safety, efficacy, pharmacological data, pharmacodynamic effects, and drug interactions. If a drug fails any of these criteria, the applicant may receive a complete response letter (CRL) or face complete rejection from regulatory agencies.
A drug applicant needs to furnish additional data about the drug after receiving a CRL, which may require additional clinical trials and increase the R&D expenditure of the drug. In some cases, drug applicants withdraw their applications and discontinue their drug trials. These factors are expected to hinder the global market during the forecast period.
Key Market Customer Landscape
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their strategies.
Global Market Customer Landscape
Who are the Major Ibuprofen API Market Companies?
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Chemino Pharma Ltd. - The company is engaged in the manufacturing of pharmaceutical products such as active pharmaceutical ingredients, intermediate chemicals, and trading of solvents such as toluene, ISO propyl alcohol, phenol, and ethyl acetate. The key offerings of the company include nonsteroidal ibuprofen anti-inflammatory drugs.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:
- Arch Pharmalabs Ltd.
- Athos Chemicals Pvt. Ltd.
- Azelis SA
- BASF SE
- Dr. Reddys Laboratories Ltd.
- Granules India Ltd.
- HELM AG
- IOL Chemicals and Pharmaceuticals Ltd.
- Mallinckrodt Plc
- Octavius Pharma Pvt Ltd.
- Piramal Enterprises Ltd.
- Rochem International Inc.
- SI Group Inc.
- Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd.
- Solara Active Pharma Sciences Ltd.
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
What is the Fastest-Growing Segment in the Market?
The market share growth by the pharmaceutical companies segment will be significant during the forecast period. This is one of the most popular products in this segment owing to its wide range of applications, such as easing mild to moderate pain, including toothache, migraine, and menstrual cramps. It is used as an analgesic and antipyretic agent and has anti-inflammatory properties. This is also used in the treatment of various conditions, such as rheumatoid arthritis and osteoarthritis.
Get a glance at the market contribution of various segments Request a PDF Sample
The pharmaceutical companies segment was valued at USD 130.40 million in 2017 and continued to grow until 2021. Ibuprofen inhibits the production of prostaglandins, which are hormones that cause pain and inflammation. It is a popular choice for the treatment of pain, as it is relatively safe and effective. These factors will drive the growth of the segment during the forecast period.
Which are the Key Regions for the Market?
For more insights on the market share of various regions Request PDF Sample now!
Asia is estimated to contribute 42% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The growth of the market is attributed to factors such as the growing prevalence of migraine, chronic disorders, and other disorders. The manufacturing of pharmaceutical drugs, such as ibuprofen API, is increasing in Asia due to low manufacturing costs in China and India. As a result, the number of production facilities has increased. The increasing geriatric population will also drive the growth of the market in Asia. The geriatric population is more prone to chronic diseases. Hence, the anticipated rise in population is expected to fuel the demand for innovative pain relief. These factors will drive the growth of the market in Asia during the forecast period.
Segment Overview
The market research report forecasts market growth by revenue at global, regional, and country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
- End-user Outlook (USD Million, 2017 - 2027)
- Pharmaceutical companies
- Contract manufacturing organizations
- Product Outlook (USD Million, 2017 - 2027)
- Prescription
- Over-the-counter
- Region Outlook (USD Million, 2017 - 2027)
- North America
- The U.S.
- Canada
- Europe
- The U.K.
- Germany
- France
- Rest of Europe
- Asia
- China
- India
- ROW
- Australia
- Argentina
- Rest of the world
- North America
Market Analyst Overview
The Market is influenced by factors such as Basis Point Share (BPS), with a focus on sustainable manufacturing and environmentally restrictive impacts. The synthesis of Ibuprofen API involves adherence to production guidelines, raw material sourcing, and exploring advanced synthesis routes. This is a key component in pharmaceutical formulations, particularly in nonsteroidal anti-inflammatory drugs (NSAIDs). It is widely used for its analgesic, antipyretic, and anti-inflammatory actions, making it a popular choice for OTC sales.
In drug development, effective drug candidate identification is crucial. This involves the use of bioinformatics, high throughput screening, and combinatorial chemistry to discover potential candidates. Technological innovations in drug discovery, including high-throughput screening, multi-detector readers, automation, and imaging hardware and software, are driving growth in the market. End users, including contract manufacturing organisations (CMOs), play a significant role in the market. The market is expected to witness sales growth, especially in women's healthcare, due to its effective results in managing body pain, joint pain, and various inflammatory conditions such as ankylosing spondylitis, lupus, gout, psoriatic arthritis, and pseudogout. However, challenges such as labour costs, taxation, healthcare infrastructure, stress, pollution, and biological heredity may impact market dynamics. Additionally, the use of Ibuprofen API in patients with cardiovascular diseases, including patent ductus arteriosus in premature newborns, requires careful consideration of dosage and administration, either orally or intravenously, to avoid adverse effects.
|
Ibuprofen API Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
151 |
|
Base year |
2022 |
|
Historic period |
2017-2021 |
|
Forecast period |
2023-2027 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 2.53% |
|
Market growth 2023-2027 |
USD 31.68 million |
|
Market structure |
Fragmented |
|
YoY growth 2022-2023(%) |
1.76 |
|
Regional analysis |
Asia, North America, Europe, and Rest of World (ROW) |
|
Performing market contribution |
Asia at 42% |
|
Key countries |
US, Germany, UK, India, and China |
|
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Arch Pharmalabs Ltd., Athos Chemicals Pvt. Ltd., Azelis SA, BASF SE, Chemino Pharma Ltd., Dr Reddys Laboratories Ltd., Granules India Ltd., HELM AG, IOL Chemicals and Pharmaceuticals Ltd., Mallinckrodt Plc, Octavius Pharma Pvt Ltd., Piramal Enterprises Ltd., Rochem International Inc., SI Group Inc., Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd., Solara Active Pharma Sciences Ltd., Strides Pharma Science Ltd., Teva Pharmaceutical Industries Ltd., Titan Lab Pvt Ltd., and Otto Brandes GmbH |
|
Market dynamics |
Parent market analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
What are the Key Data Covered in this Market Report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the market growth and forecasting of the market between 2023 and 2027
- Precise estimation of the size of the market size and its contribution to the parent market
- Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
- Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
- Thorough market growth analysis of the market’s competitive landscape and detailed information about companies
- Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2022
- 3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
- 4.1 Global ibuprofen API market 2017 - 2021
- Exhibit 18: Historic Market Size – Data Table on Global ibuprofen API market 2017 - 2021 ($ million)
- 4.2 End user Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size – End user Segment 2017 - 2021 ($ million)
- 4.3 Product Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size – Product Segment 2017 - 2021 ($ million)
- 4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
- 4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by End-user
- 6.1 Market segments
- Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
- Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
- 6.2 Comparison by End-user
- Exhibit 32: Chart on Comparison by End-user
- Exhibit 33: Data Table on Comparison by End-user
- 6.3 Pharmaceutical companies - Market size and forecast 2022-2027
- Exhibit 34: Chart on Pharmaceutical companies - Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Pharmaceutical companies - Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Pharmaceutical companies - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Pharmaceutical companies - Year-over-year growth 2022-2027 (%)
- 6.4 Contract manufacturing organizations - Market size and forecast 2022-2027
- Exhibit 38: Chart on Contract manufacturing organizations - Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Contract manufacturing organizations - Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Contract manufacturing organizations - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Contract manufacturing organizations - Year-over-year growth 2022-2027 (%)
- 6.5 Market opportunity by End-user
- Exhibit 42: Market opportunity by End-user ($ million)
- Exhibit 43: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Product
- 7.1 Market segments
- Exhibit 44: Chart on Product - Market share 2022-2027 (%)
- Exhibit 45: Data Table on Product - Market share 2022-2027 (%)
- 7.2 Comparison by Product
- Exhibit 46: Chart on Comparison by Product
- Exhibit 47: Data Table on Comparison by Product
- 7.3 Prescription - Market size and forecast 2022-2027
- Exhibit 48: Chart on Prescription - Market size and forecast 2022-2027 ($ million)
- Exhibit 49: Data Table on Prescription - Market size and forecast 2022-2027 ($ million)
- Exhibit 50: Chart on Prescription - Year-over-year growth 2022-2027 (%)
- Exhibit 51: Data Table on Prescription - Year-over-year growth 2022-2027 (%)
- 7.4 Over-the-counter - Market size and forecast 2022-2027
- Exhibit 52: Chart on Over-the-counter - Market size and forecast 2022-2027 ($ million)
- Exhibit 53: Data Table on Over-the-counter - Market size and forecast 2022-2027 ($ million)
- Exhibit 54: Chart on Over-the-counter - Year-over-year growth 2022-2027 (%)
- Exhibit 55: Data Table on Over-the-counter - Year-over-year growth 2022-2027 (%)
- 7.5 Market opportunity by Product
- Exhibit 56: Market opportunity by Product ($ million)
- Exhibit 57: Data Table on Market opportunity by Product ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 59: Chart on Market share by geography 2022-2027 (%)
- Exhibit 60: Data Table on Market share by geography 2022-2027 (%)
- 9.2 Geographic comparison
- Exhibit 61: Chart on Geographic comparison
- Exhibit 62: Data Table on Geographic comparison
- 9.3 Asia - Market size and forecast 2022-2027
- Exhibit 63: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 64: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 65: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 66: Data Table on Asia - Year-over-year growth 2022-2027 (%)
- 9.4 North America - Market size and forecast 2022-2027
- Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
- 9.5 Europe - Market size and forecast 2022-2027
- Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- 9.7 US - Market size and forecast 2022-2027
- Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
- 9.8 India - Market size and forecast 2022-2027
- Exhibit 83: Chart on India - Market size and forecast 2022-2027 ($ million)
- Exhibit 84: Data Table on India - Market size and forecast 2022-2027 ($ million)
- Exhibit 85: Chart on India - Year-over-year growth 2022-2027 (%)
- Exhibit 86: Data Table on India - Year-over-year growth 2022-2027 (%)
- 9.9 China - Market size and forecast 2022-2027
- Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)
- 9.10 Germany - Market size and forecast 2022-2027
- Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
- 9.11 UK - Market size and forecast 2022-2027
- Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
- 9.12 Market opportunity by geography
- Exhibit 99: Market opportunity by geography ($ million)
- Exhibit 100: Data Tables on Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 101: Impact of drivers and challenges in 2022 and 2027
- 10.4 Market trends
11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 103: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 104: Impact of key risks on business
12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 105: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 106: Matrix on vendor position and classification
- 12.3 Athos Chemicals Pvt. Ltd.
- Exhibit 107: Athos Chemicals Pvt. Ltd. - Overview
- Exhibit 108: Athos Chemicals Pvt. Ltd. - Product / Service
- Exhibit 109: Athos Chemicals Pvt. Ltd. - Key offerings
- 12.4 Azelis SA
- Exhibit 110: Azelis SA - Overview
- Exhibit 111: Azelis SA - Product / Service
- Exhibit 112: Azelis SA - Key offerings
- 12.5 BASF SE
- Exhibit 113: BASF SE - Overview
- Exhibit 114: BASF SE - Business segments
- Exhibit 115: BASF SE - Key news
- Exhibit 116: BASF SE - Key offerings
- Exhibit 117: BASF SE - Segment focus
- 12.6 Chemino Pharma Ltd.
- Exhibit 118: Chemino Pharma Ltd. - Overview
- Exhibit 119: Chemino Pharma Ltd. - Product / Service
- Exhibit 120: Chemino Pharma Ltd. - Key offerings
- 12.7 Dr Reddys Laboratories Ltd.
- Exhibit 121: Dr Reddys Laboratories Ltd. - Overview
- Exhibit 122: Dr Reddys Laboratories Ltd. - Business segments
- Exhibit 123: Dr Reddys Laboratories Ltd. - Key offerings
- Exhibit 124: Dr Reddys Laboratories Ltd. - Segment focus
- 12.8 Granules India Ltd.
- Exhibit 125: Granules India Ltd. - Overview
- Exhibit 126: Granules India Ltd. - Product / Service
- Exhibit 127: Granules India Ltd. - Key news
- Exhibit 128: Granules India Ltd. - Key offerings
- 12.9 IOL Chemicals and Pharmaceuticals Ltd.
- Exhibit 129: IOL Chemicals and Pharmaceuticals Ltd. - Overview
- Exhibit 130: IOL Chemicals and Pharmaceuticals Ltd. - Business segments
- Exhibit 131: IOL Chemicals and Pharmaceuticals Ltd. - Key offerings
- Exhibit 132: IOL Chemicals and Pharmaceuticals Ltd. - Segment focus
- 12.10 Octavius Pharma Pvt Ltd.
- Exhibit 133: Octavius Pharma Pvt Ltd. - Overview
- Exhibit 134: Octavius Pharma Pvt Ltd. - Product / Service
- Exhibit 135: Octavius Pharma Pvt Ltd. - Key offerings
- 12.11 Piramal Enterprises Ltd.
- Exhibit 136: Piramal Enterprises Ltd. - Overview
- Exhibit 137: Piramal Enterprises Ltd. - Business segments
- Exhibit 138: Piramal Enterprises Ltd. - Key offerings
- Exhibit 139: Piramal Enterprises Ltd. - Segment focus
- 12.12 Rochem International Inc.
- Exhibit 140: Rochem International Inc. - Overview
- Exhibit 141: Rochem International Inc. - Product / Service
- Exhibit 142: Rochem International Inc. - Key offerings
- 12.13 SI Group Inc.
- Exhibit 143: SI Group Inc. - Overview
- Exhibit 144: SI Group Inc. - Product / Service
- Exhibit 145: SI Group Inc. - Key offerings
- 12.14 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd.
- Exhibit 146: Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Overview
- Exhibit 147: Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Product / Service
- Exhibit 148: Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Key offerings
- 12.15 Solara Active Pharma Sciences Ltd.
- Exhibit 149: Solara Active Pharma Sciences Ltd. - Overview
- Exhibit 150: Solara Active Pharma Sciences Ltd. - Product / Service
- Exhibit 151: Solara Active Pharma Sciences Ltd. - Key offerings
- 12.16 Strides Pharma Science Ltd.
- Exhibit 152: Strides Pharma Science Ltd. - Overview
- Exhibit 153: Strides Pharma Science Ltd. - Business segments
- Exhibit 154: Strides Pharma Science Ltd. - Key offerings
- Exhibit 155: Strides Pharma Science Ltd. - Segment focus
- 12.17 Teva Pharmaceutical Industries Ltd.
- Exhibit 156: Teva Pharmaceutical Industries Ltd. - Overview
- Exhibit 157: Teva Pharmaceutical Industries Ltd. - Business segments
- Exhibit 158: Teva Pharmaceutical Industries Ltd. - Key news
- Exhibit 159: Teva Pharmaceutical Industries Ltd. - Key offerings
- Exhibit 160: Teva Pharmaceutical Industries Ltd. - Segment focus
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 161: Inclusions checklist
- Exhibit 162: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 163: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 164: Research methodology
- Exhibit 165: Validation techniques employed for market sizing
- Exhibit 166: Information sources
- 13.5 List of abbreviations
- Exhibit 167: List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
PURCHASE FULL REPORT OF
ibuprofen api market market
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
- Off-the-shelf research reports
- Reports can be tailored to meet the customer's needs
- Trusted by more than 100 fortune 500 organizations
- Information about the market's key drivers, trends, and challenges
- Parent market analysis
- Every week, 50,000 people visit our subscription platform
- Detailed vendors report with competitive landscape
- Covid-19 impact and recovery analysis
- Data on revenue-generating market segments
- Details on the market shares of various regions
- Five-force market analysis